Korea United Pharm Inc. (033270.KS) KSC

18,850.00

+90(+0.48%)

Updated at October 20 09:18AM

Currency In KRW

Valuation

Market Cap267.54B
Enterprise Value249.49B
P/E Ratio8.16
PEG Ratio0.28
Price/Sales Ratio0.96
Price/Book Ratio0.66
Enterprise/Revenue0.94
Enterprise/EBITDA4.62

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.12
Operating Margin0.18

Management Effectiveness

Return On Assets0.07
Return On Equity0.08

Income Statement

Revenue288.71B
Revenue/Share19,643.3
Gross Profit163.97B
EBITDA57.84B
Net Income32.45B
Diluted EPS2,205.77

Balance Sheet

Total Cash130.49B
Total Cash/Share8,954.34
Total Debt14.95B
Total Debt/Equity0.04
Current Ratio5.44
Book Value Per Share28,386.76

Price History

52-Week Change-13.55
52-Week High22,450
52-Week Low17,250
Moving Average 50 Days19,913.6
Moving Average 200 Days19,873.4

Statistics

Average Volume39,224
Shares Outstanding14.71M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate450
Trailing Annual Dividend Yield2.4
Payout Ratio0
Last Split Factor51:50
Last Split DateJanuary 20, 2014